InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Scholar Rock Holding Corp

SRRK Clue Score52
United States Fiscal year ends December CIK 0001727196 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Balanced

Individual transactions

44
Insider
Date
Role
Action
Shares
Price
Amount
Katie Peng
1 Jul 2026
Director
Sold on a plan
21
$54.96
$1.15K
Katie Peng
1 Jul 2026
Director
Sold on a plan
2,437
$54.25
$132.21K
Katie Peng
1 Jul 2026
Director
Sold on a plan
2,988
$53.56
$160.04K
Joshua Reed
1 Jul 2026
Director
Sold on a plan
948
$54.28
$51.46K
Joshua Reed
1 Jul 2026
Director
Sold on a plan
2,105
$53.50
$112.61K
Kristina Burow
1 Jul 2026
Director
Sold on a plan
948
$54.28
$51.46K
Kristina Burow
1 Jul 2026
Director
Sold on a plan
2,105
$53.49
$112.60K
Michael Gilman
1 Jul 2026
Director
Sold on a plan
43
$54.81
$2.36K
Michael Gilman
1 Jul 2026
Director
Sold on a plan
1,155
$54.23
$62.63K
Michael Gilman
1 Jul 2026
Director
Sold on a plan
1,346
$53.54
$72.07K
Jeffrey S. Flier
1 Jul 2026
Director
Sold on a plan
15
$54.88
$823.14
Jeffrey S. Flier
1 Jul 2026
Director
Sold on a plan
1,470
$54.24
$79.73K
Jeffrey S. Flier
1 Jul 2026
Director
Sold on a plan
1,568
$53.53
$83.94K
Mo Qatanani
23 Feb 2026
Chief Scientific Officer
Sold on a plan
200
$48.48
$9.70K
Mo Qatanani
23 Feb 2026
Chief Scientific Officer
Sold on a plan
857
$47.86
$41.01K
Mo Qatanani
23 Feb 2026
Chief Scientific Officer
Sold on a plan
7,427
$46.94
$348.64K
Mo Qatanani
22 Jan 2026
Chief Scientific Officer
Sold on a plan
12,779
$46.85
$598.75K
Mo Qatanani
22 Jan 2026
Chief Scientific Officer
Sold on a plan
2,119
$45.87
$97.19K
Katie Peng
16 Dec 2025
Director
Sold on a plan
280
$44.63
$12.50K
Katie Peng
16 Dec 2025
Director
Sold on a plan
726
$43.88
$31.85K
Katie Peng
16 Sep 2025
Director
Sold on a plan
76
$33.20
$2.52K
Katie Peng
16 Sep 2025
Director
Sold on a plan
930
$32.48
$30.20K
Jeffrey S. Flier
16 Jul 2025
Director
Sold on a plan indirect
11,136
$40.02
$445.69K
Mo Qatanani
8 Jul 2025
Chief Scientific Officer
Sold on a plan
24,066
$34.44
$828.90K
Katie Peng
16 Jun 2025
Director
Sold on a plan
54
$32.53
$1.76K
Katie Peng
16 Jun 2025
Director
Sold on a plan
2,977
$31.96
$95.13K
Akshay Vaishnaw
29 May 2025
President of R&D
Sold on a plan
1,620
$30.01
$48.61K
Akshay Vaishnaw
29 May 2025
President of R&D
Sold on a plan
5,130
$29.63
$152.00K
Joshua Reed
29 May 2025
Director
Sold on a plan
500
$30.04
$15.02K
Joshua Reed
29 May 2025
Director
Sold on a plan
4,900
$29.68
$145.44K
Richard Brudnick
29 May 2025
Director
Sold on a plan
1,400
$30.00
$42.00K
Richard Brudnick
29 May 2025
Director
Sold on a plan
4,675
$29.63
$138.53K
Michael Gilman
29 May 2025
Director
Sold on a plan
2,745
$29.83
$81.90K
Michael Gilman
29 May 2025
Director
Sold on a plan
630
$29.22
$18.41K
Kristina Burow
29 May 2025
Director
Sold on a plan
4,400
$29.83
$131.27K
Kristina Burow
29 May 2025
Director
Sold on a plan
1,000
$29.24
$29.24K
Jeffrey S. Flier
29 May 2025
Director
Sold on a plan
4,975
$29.84
$148.43K
Jeffrey S. Flier
29 May 2025
Director
Sold on a plan
1,100
$29.23
$32.15K
Katie Peng
17 Mar 2025
Director
Sold on a plan
1,006
$34.42
$34.63K
Mo Qatanani
18 Feb 2025
Chief Scientific Officer
Sold on a plan
4,135
$36.83
$152.29K
Srinivas Akkaraju
7 Oct 2024
Director
Sold on a plan indirect
155,713
$32.50
$5.06M
Srinivas Akkaraju
7 Oct 2024
Director
Sold on a plan indirect
510,000
$30.00
$15.30M
Srinivas Akkaraju
7 Oct 2024
Director
Sold on a plan indirect
510,000
$27.50
$14.03M
Edward H Myles
2 Nov 2023
COO & CFO
Sold on a plan
35,007
$12.51
$438.04K
Show all 194 transactions →

What was left out

Form 4 filings counted 282
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 13
Sales on a Rule 10b5-1 plan 44
Sales straight out of an exercise 49
Sales at will 63
Transactions with no price 0
Shares from compensation/vesting 30,452,736
Sales filed before the plan box existed 7
History held since 31 May 2018